1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
- Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
- 2010
- Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006
- 2009
- Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles
- Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas:relative risks and time-trends in the Swedish Biologics Register
- 2008
- Autoantibodies in rheumatoid arthritis: Anti-citrullinated protein antibodies (ACPA) and type II collagen specificities (B cells and autoantibodies: diagnosis and pathophysiology)
- 2007
- A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity
- 2006
- Swedish registers to examine drug safety and clinical issues in RA
- 2005
-
CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis
Larsson, E ; Harris, H E ; Palmblad, K ; Månsson, Bengt LU
; Saxne, Tore
LU
and Klareskog, L
(2005)
In Annals of the Rheumatic Diseases
64(3).
p.494-496
Mark
- Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
- Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists